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Letters to the Editor 127yellow). Chemogram analysis enables one to divide the scan into 2-mm
blocks and quantify the amount of lipid on a scale of 0 to 1,000, termed
the lipid core burden index (LCBI).
Similar toHou et al., we captured 2 distinct patterns of CAV byNIRS
during the routine hemodynamic and angiographic assessment in long-
term survivors after heart transplantation. Simultaneous gray-scale IVUS
and NIRS scans in the 2 allograft recipients 11 and 19 years after the
transplantation demonstrated fibrotic (Fig. 1) and lipid-rich plaques
(Fig. 2), respectively. Interestingly, the NIRS chemogram showed lipid-
rich regions, even for the angiographically normal-appearing vessel in the
latter patient who did not receive statin therapy.
The 2 different NIRS scans of CAV in transplant recipients may
correspond to the difference in elapsed survival time from trans-
plantation and use of medical therapy. Autopsy studies have
confirmed that in the first 5 years after transplantation, CAV
plaques are mostly composed of fibrotic tissue, whereas lipid
accumulation is seen later. Gray-scale IVUS studies have provided
some insight into the etiology of CAV in survivors 1 to 9 years
post-transplantation (4). They have revealed diffuse and circumferen-
tial lesions in mid and distal coronary segments, suggestive of the
fibrotic tissue. Focal and noncircumferential lesions observed in the
proximal segment of the vessel early after transplantation indicated
pre-existing atherosclerotic lesions. Radiofrequency (RF) analysis by
IVUS (virtual histology) suggested that lipid-rich regions in neointima
increased and fibrosis decreased with time over 1 to 20 years after the
heart transplantation (5). However, the accuracy of RF-IVUS in
lipid-rich plaque determination has been questioned, and character-
ization of the IH by other imaging modalities should be confirmatory.
Interestingly, the accelerated lipid-rich atherosclerotic process in CAV
seems to be slower compared with vein coronary graft plaques and
in-stent restenosis development. This insidious process is often a result
of younger vasculature of the allografts, which is likely to be devoid of
pre-existing disease. The immunosuppressive therapy could also con-
tribute to the delay in the process; statin supplementation further
enhances the immunosuppressive efficacy of calcineurin inhibitors.
New intravascular imaging modalities may improve CAV
Figure 2. Lipid-Rich Cardiac Allograft Vasculopathy
IVUS (A), angiography (B), and NIRS (C) scans of the medial right coronary arte
of the presented IVUS cross-sectional image. White lines (B and C) represent a
sent 2-mm blocks. The patient underwent heart transplantation 19 years earlier
severe left ventricular dysfunction. His medical regimen (tacrolimus, sirolimus, n
nary angiography revealed a focal 80% lesion in the mid RCA, IVUS minimal lum
(blue lines). Abbreviations as in Figure 1.screening in allograft recipients. They would contribute to thenderstanding of the disease process and help to better define
anagement strategies. Allograft vasculopathy is not unique to
eart transplantation and may occur similarly in all transplanted
rgans, and the knowledge gained from coronary screening may
ave wider implications.
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Prognostic Value of
Coronary CT Angiography
We read with interest the paper from Andreini et al. (1) that provided
more evidence on the prognostic value of cardiac computed tomography
CA) in a 24-year-old male patient. The white arrow (B) indicates the location
ion of the angiogram corresponding to the NIRS scan. Yellow lines (C) repre-
r aortic root wrapping surgery for an aortic root aneurysm that resulted in
ipine, losartan, and aspirin) did not include any lipid-lowering therapy. Coro-
area  3.5 cm2, and a lipid core burden index in a 4-mm segment  524ry (R
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enangiography (CTA) in patients referred for evaluation of possible coronary
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Letters to the Editor128artery disease (CAD), an area of research in need of long term follow up
studies like this one (mean follow-up 4 years).
However, we noticed that the mean pre-test probability of CAD
n the study population was 42.5%, with one-quarter of the patients
aving a high CAD probability, which is not in line with the most
avored low-to-intermediate probability population referred for
TA for the exclusion of possible CAD (2), and that could explain
he higher-than-expected hard event rate for a stable CAD popu-
ation (almost 1 out of 2 patients with obstructive CAD dying or
aving a nonfatal myocardial infarction [MI]) in the follow-up (3).
This could have been the result of having included patients
admitted to the hospital because of new-onset chest pain (43%), a
subset that could be considered as possible acute coronary syndrome
(ACS) unstable angina/non–ST-segment elevation MI) and can
explain the higher than expected rate of major (death/MI) events in
the follow-up (event-free survival of 54%). In how many cases was
an ACS diagnosis confirmed? If any, the authors should have
excluded these patients from the study. We fully agree that CTA
can provide useful prognostic information beyond the exclusion of
obstructive CAD, but the inclusion of patients with possible ACS
and high CAD probability could have lead to an overestimation of
the prognostic power of CTA.
Another striking point was the fact that 45% of patients had
hypercholesterolemia but only 26% were treated with statins. Further,
statins turned out in multivariable analysis to be independent predic-
tors for hard events. Likewise, 26% of the population (with suspected
CAD) was taking aspirin, which is not generally recommended as
primary prevention. Use of aspirin was also an independent predictor
of all cardiac events. It would have been interesting to know if the use
of these drug groups is allocated to a more severe subset of patients
(more frequently used in obstructive vs. nonobstructive vs. normal
patients) and in this way are just a surrogate marker of higher disease
burden. Likewise, it would be of interest to know if patients were
already taking these drugs before the CTA or if they were just started
after significant disease was identified and, in this way, they could not
have had enough time to come out with its protective effects in a more
severe CAD subgroup of patients.
The Framingham risk score (FRS) was used to estimate the
cardiovascular risk of this Italian cohort of patients; it could have
been more accurately estimated with the European-based
HeartScore (4). This could have also influenced the results, as the
multivariable analysis models were adjusted for the FRS.
It is not mentioned that the events were independently adjudi-
cated and that the adjudication event committee is an experienced
one with acceptable intra-committee reproducibility for the adju-
dication of events. This point is of utmost relevance in a report of
this nature. In addition, regarding revascularizations, we agree that
early revascularizations should be excluded to avoid the influence of
CTA results in patient management but most of the previous
studies considered early as 30 days (5) and not 6 months like in the
paper from Andreini et al. (1). This could have also influenced the
results, as revascularizations in obstructive CAD group are likely to
have happened sooner after the CTA and in this regard could have
underestimated the prognostic value of obstructive versus nonob-
structive CAD. Further, it is not mentioned whether the revascu-arizations were ischemia-driven (i.e., only for obstructive lesions)
r not.
Despite the fact that authors have scored hierarchically the
laque type per segment (i.e., in case of presence of 2 plaques,
alcified and noncalcified, only one was scored and labeled as
alcified) which underestimates the frequency of noncalcified
laques, in the univariate analysis, these were found to be indepen-
ent predictors of hard events. This methodology seems to us to be
ounterintuitive, since it has been reported many times that
igh-risk plaques (i.e., plaques prone to rupture and associated with
n event) are those noncalcified or mixed, which could have come
ut as strong predictors also in the multivariate analysis if the
uthors had not underscored them.
Undoubtedly, this is a report with an important message, but we
eel that the above-mentioned points should be further explained to
trengthen the conclusions.
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REPLY
The comments of Garcia-Garcia and Goncalves are relevant and
allow us to expand on some results of our study (1). First, we found
